This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Aggressive systemic mastocytosis: midostaurin is safe, feasible and associated with durable response post‐haploidentical allogeneic stem cell transplant. (21st May 2019)
Record Type:
Journal Article
Title:
Aggressive systemic mastocytosis: midostaurin is safe, feasible and associated with durable response post‐haploidentical allogeneic stem cell transplant. (21st May 2019)
Main Title:
Aggressive systemic mastocytosis: midostaurin is safe, feasible and associated with durable response post‐haploidentical allogeneic stem cell transplant